Log in to save to my catalogue

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with i...

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2858986795

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism

About this item

Full title

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism

Publisher

England

Journal title

Hypertension research, 2024-02, Vol.47 (2), p.311-321

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Our prior study has suggested that percutaneous superselective adrenal arterial embolization (SAAE) with ethanol reduces blood pressure in patients with primary aldosteronism. This study aimed to compare the efficacy of SAAE with mineralocorticoid receptor antagonists (MRA) in treating patients with idiopathic hyperaldosteronism. In this prospectiv...

Alternative Titles

Full title

A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2858986795

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2858986795

Other Identifiers

ISSN

0916-9636,1348-4214

E-ISSN

1348-4214

DOI

10.1038/s41440-023-01420-w

How to access this item